Kenneth d'Entremont - Net Worth and Insider Trading
Kenneth d'Entremont Net Worth
The estimated net worth of Kenneth d'Entremont is at least $1 Million dollars as of 2024-06-23. Kenneth d'Entremont is the Director, Senior Officer of Medexus Pharmaceuticals Inc and owns about 643,889 shares of Medexus Pharmaceuticals Inc (TSX:MDP) stock worth over $1 Million. Details can be seen in Kenneth d'Entremont's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kenneth d'Entremont has not made any transactions after 2023-06-29 and currently still holds the listed stock(s).
Transaction Summary of Kenneth d'Entremont
Kenneth d'Entremont Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kenneth d'Entremont owns 1 companies in total, including Medexus Pharmaceuticals Inc (TSX:MDP) .
Click here to see the complete history of Kenneth d'Entremont’s form 4 insider trades.
Insider Ownership Summary of Kenneth d'Entremont
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:MDP | Medexus Pharmaceuticals Inc | 2023-06-29 | Director & Senior Officer |
Kenneth d'Entremont Latest Holdings Summary
Kenneth d'Entremont currently owns a total of 1 stock. Kenneth d'Entremont owns 643,889 shares of Medexus Pharmaceuticals Inc (TSX:MDP) as of June 29, 2023, with a value of $1 Million.
Latest Holdings of Kenneth d'Entremont
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:MDP | Medexus Pharmaceuticals Inc | 2023-06-29 | 643,889 | 1.69 | 1,088,172 |
Holding Weightings of Kenneth d'Entremont
Kenneth d'Entremont Form 4 Trading Tracker
According to the SEC Form 4 filings, Kenneth d'Entremont has made a total of 36 transactions in Medexus Pharmaceuticals Inc (TSX:MDP) over the past 5 years, including 34 buys and 2 sells. The most-recent trade in Medexus Pharmaceuticals Inc is the acquisition of 3,800 shares on June 29, 2023, which cost Kenneth d'Entremont around $6,346.
Insider Trading History of Kenneth d'Entremont
- 1
Kenneth d'Entremont Trading Performance
Kenneth d'Entremont Ownership Network
Kenneth d'Entremont Owned Company Details
What does Medexus Pharmaceuticals Inc do?
Who are the key executives at Medexus Pharmaceuticals Inc?
Kenneth d'Entremont is the Director & Senior Officer of Medexus Pharmaceuticals Inc. Other key executives at Medexus Pharmaceuticals Inc include Senior Officer Marcel Pascal Konrad , Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6) Brian Peters , and Senior Officer Roland Boivin .
Medexus Pharmaceuticals Inc (TSX:MDP) Insider Trades Summary
Over the past 18 months, Kenneth d'Entremont made 2 insider transaction in Medexus Pharmaceuticals Inc (TSX:MDP) with a net purchase of 18,800. Other recent insider transactions involving Medexus Pharmaceuticals Inc (TSX:MDP) include a net purchase of 7,000 shares made by Mike Mueller , a net purchase of 93,800 shares made by Stephen William Nelson , and a net purchase of 5,100 shares made by Marcel Pascal Konrad .
In summary, during the past 3 months, insiders sold 0 shares of Medexus Pharmaceuticals Inc (TSX:MDP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Medexus Pharmaceuticals Inc (TSX:MDP) were sold and 127,900 shares were bought by its insiders, resulting in a net purchase of 127,900 shares.
Medexus Pharmaceuticals Inc (TSX:MDP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Medexus Pharmaceuticals Inc Insider Transactions
Kenneth d'Entremont Mailing Address
Above is the net worth, insider trading, and ownership report for Kenneth d'Entremont. Currently GuruFocus does not have mailing address information for Kenneth d'Entremont.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
